[go: up one dir, main page]

MX2012000066A - Administracion segura de desmopresina. - Google Patents

Administracion segura de desmopresina.

Info

Publication number
MX2012000066A
MX2012000066A MX2012000066A MX2012000066A MX2012000066A MX 2012000066 A MX2012000066 A MX 2012000066A MX 2012000066 A MX2012000066 A MX 2012000066A MX 2012000066 A MX2012000066 A MX 2012000066A MX 2012000066 A MX2012000066 A MX 2012000066A
Authority
MX
Mexico
Prior art keywords
safe
desmopressin
dispensers
desmopressin administration
nocturia
Prior art date
Application number
MX2012000066A
Other languages
English (en)
Other versions
MX343193B (es
Inventor
Seymour Fein
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43356719&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012000066(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2012000066A publication Critical patent/MX2012000066A/es
Publication of MX343193B publication Critical patent/MX343193B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/008—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised by squeezing, e.g. using a flexible bottle or a bulb

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Mechanical Engineering (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una familia de distribuidores de rocío intranasal para administrar dosis bajas uniformes de desmopresina para lograr una antidiuresis segura en pacientes humanos; los distribuidores de la invención pueden utilizarse en el tratamiento de la nocturia, enuresis nocturna primaria, incontinencia, frecuencia urinaria, diabetes insípida o cualquier enfermedad o síndrome en donde la terapia con desmopresina es útil o en donde la supresión temporal segura de la producción de orina puede conducir a efectos de la salud benéficos o una conveniencia incrementada en el control de la micción.
MX2012000066A 2009-06-18 2010-06-15 Administracion segura de desmopresina. MX343193B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26895409P 2009-06-18 2009-06-18
PCT/US2010/038663 WO2010147981A1 (en) 2009-06-18 2010-06-15 Safe desmopressin administration

Publications (2)

Publication Number Publication Date
MX2012000066A true MX2012000066A (es) 2012-02-29
MX343193B MX343193B (es) 2016-10-26

Family

ID=43356719

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000066A MX343193B (es) 2009-06-18 2010-06-15 Administracion segura de desmopresina.

Country Status (15)

Country Link
US (4) US9539302B2 (es)
EP (4) EP3278809B1 (es)
JP (3) JP6073678B2 (es)
KR (2) KR101792696B1 (es)
CN (2) CN102647993A (es)
AU (2) AU2010260211B2 (es)
BR (1) BRPI1015046A2 (es)
CA (1) CA2765221C (es)
DK (4) DK4104848T3 (es)
ES (4) ES2929471T3 (es)
MX (1) MX343193B (es)
PL (4) PL2442821T5 (es)
PT (3) PT4104848T (es)
RU (2) RU2015144851A (es)
WO (1) WO2010147981A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
MX2011006765A (es) 2008-12-22 2011-11-01 Allergan Inc Administracion intranasal de desmopresina.
ES2929471T3 (es) 2009-06-18 2022-11-29 Acerus Pharmaceuticals Usa Llc Administración segura de desmopresina
JP2014518270A (ja) * 2011-06-27 2014-07-28 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム トロイダル医薬製剤
WO2014055801A1 (en) * 2012-10-05 2014-04-10 Henkin Robert I Phosphodiesterase inhibitors for treating taste and smell disorders
US20160030435A1 (en) * 2013-03-15 2016-02-04 Robert I HENKIN Phosphodiesterase inhibitor treatment
US9814753B2 (en) 2013-07-23 2017-11-14 Serenity Pharmaceuticals Llc Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist
WO2015013453A1 (en) * 2013-07-23 2015-01-29 Allergan, Inc. Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor
EP3108245B1 (en) 2014-02-18 2020-07-22 Robert I. Henkin Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
US10286033B2 (en) * 2014-11-20 2019-05-14 Serenity Pharmaceuticals, Llc Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist
JP2018522050A (ja) * 2015-08-04 2018-08-09 インキューファーム グループ エスディーエヌ ビーエイチディー 経鼻組成物
EA202191506A1 (ru) 2018-12-19 2021-10-08 Нортик Холдингз Инк. Терапевтическая композиция интраназального лидокаина
USD959279S1 (en) 2020-04-07 2022-08-02 VB Brands LLC Spray bottle
CA3117116A1 (en) * 2020-04-13 2021-10-13 AIMIC Corp. An imaging system and method for quality and dosage control of anesthetics applied by a spray nozzle

Family Cites Families (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS171787B1 (es) 1973-11-09 1976-11-29
US4148787A (en) 1976-05-24 1979-04-10 Ferring Ab Antidiuretically effective polypeptide and a process for preparing the same
US4285858A (en) 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
CA1208558A (en) 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4771769A (en) 1982-12-20 1988-09-20 Schering Corporation Hand held metered spray dispenser
US4548922A (en) 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US4746508A (en) 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US5288497A (en) 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5731303A (en) 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
CH666813A5 (de) 1985-12-04 1988-08-31 Dean Hsieh Arzneimittel zur transdermalen verabreichung.
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5112804A (en) 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
US4944429A (en) 1987-08-28 1990-07-31 Schering Corporation Manually-operable spray dispenser with locking mechanism
US5350741A (en) 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US5154122A (en) 1989-10-20 1992-10-13 Sol Goldschmidt Shipping device for suspended piece goods
JP2951681B2 (ja) 1990-02-23 1999-09-20 株式会社資生堂 経粘膜投与用薬剤組成物
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
CN1060980A (zh) 1990-10-26 1992-05-13 蔡东林 多用电控自控微型喷雾器
US5314694A (en) 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
US5122383A (en) 1991-05-17 1992-06-16 Theratech, Inc. Sorbitan esters as skin permeation enhancers
TW279133B (es) 1990-12-13 1996-06-21 Elan Med Tech
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
US5212199A (en) 1991-05-17 1993-05-18 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5227169A (en) 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
CA2070061C (en) 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
US5464387A (en) 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
IT1255895B (it) 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
WO1995001368A1 (en) 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
EP0708657B1 (en) 1993-06-29 2001-07-25 Ferring B.V. Compositions for nasal administration of desmopressin
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5388766A (en) 1993-09-22 1995-02-14 The Procter & Gamble Company High pressure atomization systems for high viscosity products
US5358551A (en) 1993-11-16 1994-10-25 Ccpi, Inc. Turbulence inhibiting tundish and impact pad and method of using
WO1995014037A1 (en) 1993-11-17 1995-05-26 Ibah, Inc. Transparent liquid for encapsulated drug delivery
AU1677095A (en) 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5613770A (en) 1994-05-16 1997-03-25 Lite Corporation Apparatus for securing component panels in a lighting fixture
US6605060B1 (en) * 1995-06-07 2003-08-12 O'neil Alexander George Brian Patient controlled drug delivery device
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
US5849322A (en) 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
DE19610457A1 (de) 1996-03-16 1997-09-18 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung für Medien
DE19623030A1 (de) 1996-06-08 1997-12-11 Pfeiffer Erich Gmbh & Co Kg Austrag-Einheit für Medien
US5763398A (en) 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
DE19627228A1 (de) 1996-07-05 1998-01-08 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung für Medien
GB9614235D0 (en) 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
EP0943336A1 (en) 1996-09-04 1999-09-22 Dott Research Laboratory Peptide-containing pharmaceutical compositions for oral administration
DE19642976A1 (de) 1996-10-18 1998-04-23 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung für Medien
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE19723133A1 (de) 1997-06-03 1998-12-10 Caideil M P Teoranta Tourmakea Austragvorrichtung für Medien
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
HU224587B1 (hu) 1997-09-12 2005-11-28 Telefonaktiebolaget Lm Ericsson (Publ). Eljárás és berendezés mobiltelefonhoz
CA2302275C (en) 1997-09-19 2009-12-08 Shire Laboratories, Inc. Solid solution beadlet
US7335186B2 (en) 1998-03-13 2008-02-26 Alexander George Brian O'Neil Patient controlled drug delivery device
HUP0103396A3 (en) 1998-07-08 2002-05-28 Kirin Amgen Inc Wilmington Powdery preparation for mucosal administration containing polymeric medicine
US6355270B1 (en) 1999-01-11 2002-03-12 The Regents Of The University Of California Particles for oral delivery of peptides and proteins
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
DE50015073D1 (de) 1999-02-14 2008-05-15 Pfeiffer Erich Gmbh & Co Kg Spender für fliessfähige medien
AR014640A1 (es) 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
PT1183060E (pt) * 1999-05-20 2006-06-30 Kos Life Sciences Inc Sistema de atomizacao de baixa forca de nebulizacao e baixa retencao
DE19938798A1 (de) 1999-08-16 2001-03-01 Pfeiffer Erich Gmbh & Co Kg Spender für Flüssigkeiten oder für zähflüssige oder versprühbare Produkte
DE19940236A1 (de) 1999-08-25 2001-03-08 Pfeiffer Erich Gmbh & Co Kg Spender mit manuell betätigbarer Ausbringeinrichtung
DE19942792A1 (de) 1999-09-08 2001-03-15 Pfeiffer Erich Gmbh & Co Kg Spender für Medien
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US7122198B1 (en) 1999-11-30 2006-10-17 Panacea Biotec Limited Fast dissolving composition with prolonged sweet taste
CN1479609A (zh) 2000-08-11 2004-03-03 现代药品工业株式会社 肽的经口递送
GB0028575D0 (en) 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
DE10110742A1 (de) 2001-02-28 2002-09-05 Pfeiffer Erich Gmbh & Co Kg Spender für Medien
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7201296B2 (en) 2001-09-21 2007-04-10 Ing. Erich Pfeiffer Gmbh Dosing device with a pumping device
JP4210215B2 (ja) 2001-09-21 2009-01-14 インジ エリッヒ プファイファ ゲーエムベーハ 媒体リザーバを備えた投与装置とこれのためのポンプ装置
BR0212718B1 (pt) 2001-09-21 2012-01-10 dispositivo de dosagem com um reservatório de meios, bem como, com um dispositivo de bombeamento.
US20050025824A1 (en) 2001-12-14 2005-02-03 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
HUP0402661A3 (en) 2001-12-19 2008-04-28 Alza Corp Formulation and dosage form for the controlled delivery of therapeutic agents
AU2003201886A1 (en) 2002-01-16 2003-07-30 Yamanouchi Pharmaceutical Co., Ltd. Medicinal compositions for improving oral absorption
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003094886A2 (en) 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20021684A1 (it) 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
US7186692B2 (en) 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
CN1233952C (zh) 2003-09-04 2005-12-28 上海交通大学 调节入口烟气流量分配的辐射屏式过热器
EP2322198A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
AU2004312096A1 (en) 2003-12-31 2005-07-21 Cydex Pharmaceuticals, Inc. Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
DE102004044344A1 (de) 2004-09-09 2006-03-30 Ing. Erich Pfeiffer Gmbh Dosiervorrichtung
DE102004050679A1 (de) 2004-10-13 2006-04-20 Ing. Erich Pfeiffer Gmbh Dosiervorrichtung
DE102004050977A1 (de) 2004-10-14 2006-04-20 Ing. Erich Pfeiffer Gmbh Dosiervorrichtung für wenigstens ein Medium
US20090119408A1 (en) 2005-06-17 2009-05-07 France Telecom Method for managing execution by a server of an application providing at least one interactive multimedia service to at least one terminal, corresponding computer program product and server
JP2009504767A (ja) 2005-08-17 2009-02-05 フレミング・アンド・カンパニー・ファーマシューティカルズ ビタミンｂ１２鼻用スプレーおよび使用方法
CN1785448A (zh) 2005-11-11 2006-06-14 广东工业大学 医用防染式药雾吸入喷嘴
DE102006008874B4 (de) 2006-02-21 2012-06-21 Ing. Erich Pfeiffer Gmbh Dosiervorrichtung mit einer manuell betätigbaren Pumpeinrichtung
JP2009539856A (ja) 2006-06-08 2009-11-19 シーペックス ファーマシューティカルズ インコーポレイテッド インシュリン組成物
US20080119408A1 (en) * 2006-07-07 2008-05-22 Nastech Pharmaceutical Company Inc. Pth formulations for intranasal delivery
JP2010531898A (ja) * 2007-06-28 2010-09-30 サイデックス・ファーマシューティカルズ・インコーポレイテッド 鼻および眼へのコルチコステロイド水溶液送達
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
MX2011006765A (es) * 2008-12-22 2011-11-01 Allergan Inc Administracion intranasal de desmopresina.
WO2010075327A1 (en) * 2008-12-22 2010-07-01 Serenity Pharmaceuticals Corporation Desmopressin composition
ES2929471T3 (es) 2009-06-18 2022-11-29 Acerus Pharmaceuticals Usa Llc Administración segura de desmopresina
TWI598335B (zh) 2012-10-25 2017-09-11 Ｗ Ｒ 康格雷氏公司 用於製造吡啶及其烷基衍生物之改良方法、觸媒
US9814753B2 (en) * 2013-07-23 2017-11-14 Serenity Pharmaceuticals Llc Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist

Also Published As

Publication number Publication date
EP3278809B1 (en) 2019-11-20
US11419914B2 (en) 2022-08-23
JP6073678B2 (ja) 2017-02-01
DK2442821T4 (da) 2025-05-19
US20250241977A1 (en) 2025-07-31
EP4104848A1 (en) 2022-12-21
US20180369320A1 (en) 2018-12-27
PL2442821T5 (pl) 2026-01-26
US20120149643A1 (en) 2012-06-14
US20230218709A1 (en) 2023-07-13
MX343193B (es) 2016-10-26
ES2638815T5 (en) 2025-06-26
PT3679941T (pt) 2022-11-10
DK4104848T3 (da) 2024-01-02
PT4104848T (pt) 2024-01-04
RU2569756C2 (ru) 2015-11-27
DK3278809T3 (da) 2020-02-24
ES2929471T3 (es) 2022-11-29
PL2442821T3 (pl) 2018-04-30
AU2010260211B2 (en) 2016-04-21
DK3679941T3 (da) 2022-11-14
EP3679941A1 (en) 2020-07-15
EP2442821A1 (en) 2012-04-25
JP2016014059A (ja) 2016-01-28
DK2442821T3 (en) 2017-10-02
US9539302B2 (en) 2017-01-10
CA2765221A1 (en) 2010-12-23
EP3278809A1 (en) 2018-02-07
EP4104848B1 (en) 2023-09-27
PL4104848T3 (pl) 2024-03-25
EP2442821B1 (en) 2017-06-14
AU2016204306B2 (en) 2018-03-29
WO2010147981A1 (en) 2010-12-23
RU2012101619A (ru) 2013-07-27
JP6166320B2 (ja) 2017-07-19
AU2010260211A1 (en) 2012-01-12
EP3679941B1 (en) 2022-08-10
JP6501826B2 (ja) 2019-04-17
JP2012530708A (ja) 2012-12-06
AU2016204306A1 (en) 2016-07-14
PT2442821T (pt) 2017-09-29
RU2015144851A (ru) 2019-01-10
ES2773694T3 (es) 2020-07-14
PL3679941T3 (pl) 2023-04-17
EP2442821A4 (en) 2013-07-31
PL3278809T3 (pl) 2020-06-15
CN108295241A (zh) 2018-07-20
JP2017160263A (ja) 2017-09-14
KR102059255B1 (ko) 2019-12-24
KR101792696B1 (ko) 2017-11-02
KR20170123713A (ko) 2017-11-08
CN102647993A (zh) 2012-08-22
ES2638815T3 (es) 2017-10-24
KR20120046176A (ko) 2012-05-09
CA2765221C (en) 2017-10-03
US12090190B2 (en) 2024-09-17
BRPI1015046A2 (pt) 2016-04-12
EP2442821B2 (en) 2025-02-12
ES2969281T3 (es) 2024-05-17

Similar Documents

Publication Publication Date Title
MX343193B (es) Administracion segura de desmopresina.
NZ593613A (en) Intranasal desmopressin administration
NZ700824A (en) Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
MX2011012183A (es) Composicion farmaceutica para el tratamiento de enfermedades cardiacas.
NZ596041A (en) Use of guanethidine for treating hypertension by local vascular delivery
EP3195868A3 (en) Therapeutic use of a tlr agonist and combination therapy
NZ701038A (en) Treating acute decompensated heart failure with relaxin
ZA201201060B (en) Combination of an oxidant,a photosensitizer and a wound healing agent for oral disinfection and treatment or oral disease
EP2216024A3 (en) Use of Ranolazine for the treatment of cardiovascular diseases
NZ612455A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
NZ594056A (en) New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
WO2011020064A3 (en) Low-profile intraluminal light delivery system and methods of using the same
UA105644C2 (uk) Способи лікування легеневих порушень складами ліпосомального амікацину
PH12018500023A1 (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
NZ576424A (en) Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
NZ612717A (en) Treatment of pain associated with dislocation of basal endometrium
NZ598600A (en) Therapeutic agent for rhinitis
MX2009007247A (es) Metodo para el tratamiento de afecciones asociadas con actividad aumentada de 5-lipoxigenasa y/o leucotrienos.
WO2012079093A3 (en) Dosage and administration of bispecific scfv conjugates
MX2012007875A (es) Uso de derivados de 5-[[2, 3-dimetil-2h-indazol-6-il)-metilamino]- 2-pirimidil] amino]-2-metilbencensulfonamida en transtornos oculares.
GEP20146067B (en) Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases
WO2010107251A2 (ko) 파카스트리사민을 유효성분으로 함유하는 과증식성 피부질환과 악성흑생종의 예방 또는 치료용 약학적 조성물
WO2011056850A3 (en) Linaclotide for the treatment of chronic constipation
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
CN102380167A (zh) 口腔溃疡护理治疗仪

Legal Events

Date Code Title Description
FG Grant or registration